COVID-19 AND BRONCHIAL ASTHMA

Severe coronavirus disease-19 (COVID-19) presents with progressive dyspnea, resulting from acute lung inflammatory edema leading to hypoxia. Asthma has been cited as a potential risk factor for severe COVID-19 like other diseases that affect the respiratory tract. However, so far conflicting results...

Full description

Bibliographic Details
Main Authors: D. Dimov, T. Atanasov
Format: Article
Language:English
Published: Trakia University 2021-06-01
Series:Trakia Journal of Sciences
Subjects:
Online Access:http://tru.uni-sz.bg/tsj/Volume%2019,%202021,%20Number%202,%20Series%20Biomedical%20Sciences/12.pdf
_version_ 1819128291549773824
author D. Dimov
T. Atanasov
author_facet D. Dimov
T. Atanasov
author_sort D. Dimov
collection DOAJ
description Severe coronavirus disease-19 (COVID-19) presents with progressive dyspnea, resulting from acute lung inflammatory edema leading to hypoxia. Asthma has been cited as a potential risk factor for severe COVID-19 like other diseases that affect the respiratory tract. However, so far conflicting results have been published over the last few months and there is still no prove that there is a putative association between these two diseases. In the current mini-review we attempt to summarize the available information from the scientific literature concerning the relation of Bronchial asthma and the severity and clinical course of COVID-19 disease.
first_indexed 2024-12-22T08:25:29Z
format Article
id doaj.art-97208601742a423386089b62ac97a10a
institution Directory Open Access Journal
issn 1313-3551
language English
last_indexed 2024-12-22T08:25:29Z
publishDate 2021-06-01
publisher Trakia University
record_format Article
series Trakia Journal of Sciences
spelling doaj.art-97208601742a423386089b62ac97a10a2022-12-21T18:32:38ZengTrakia UniversityTrakia Journal of Sciences1313-35512021-06-0119218518710.15547/tjs.2021.02.012COVID-19 AND BRONCHIAL ASTHMAD. DimovT. AtanasovSevere coronavirus disease-19 (COVID-19) presents with progressive dyspnea, resulting from acute lung inflammatory edema leading to hypoxia. Asthma has been cited as a potential risk factor for severe COVID-19 like other diseases that affect the respiratory tract. However, so far conflicting results have been published over the last few months and there is still no prove that there is a putative association between these two diseases. In the current mini-review we attempt to summarize the available information from the scientific literature concerning the relation of Bronchial asthma and the severity and clinical course of COVID-19 disease.http://tru.uni-sz.bg/tsj/Volume%2019,%202021,%20Number%202,%20Series%20Biomedical%20Sciences/12.pdfcovid-19sars-cov-2bronchial asthma
spellingShingle D. Dimov
T. Atanasov
COVID-19 AND BRONCHIAL ASTHMA
Trakia Journal of Sciences
covid-19
sars-cov-2
bronchial asthma
title COVID-19 AND BRONCHIAL ASTHMA
title_full COVID-19 AND BRONCHIAL ASTHMA
title_fullStr COVID-19 AND BRONCHIAL ASTHMA
title_full_unstemmed COVID-19 AND BRONCHIAL ASTHMA
title_short COVID-19 AND BRONCHIAL ASTHMA
title_sort covid 19 and bronchial asthma
topic covid-19
sars-cov-2
bronchial asthma
url http://tru.uni-sz.bg/tsj/Volume%2019,%202021,%20Number%202,%20Series%20Biomedical%20Sciences/12.pdf
work_keys_str_mv AT ddimov covid19andbronchialasthma
AT tatanasov covid19andbronchialasthma